Biological Psychiatry Article in Press,
Corrected Proof 6 March 2007
Martin O. Joba,
Amanda Tanga,
F. Scott Hallc,
Ichiro Sorac,
George R. Uhlc,
Susan E. Bergesonb and
Rueben A. Gonzalesa, E-mail: rgonzales@mail.utexas.edu
aDivision of PharmacologyCollege of Pharmacy
bthe Waggoner Center for Alcohol and Addiction Research and Sections of Neurobiology and Molecular Genetics and MicrobiologyUniversity of Texas, Austin, Texas
cMolecular Neurobiology BranchNational Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, Maryland; AT is currently affiliated with Lexicon Genetics Inc., The Woodlands, Texas; IS is currently affiliated with the Department of Psychobiology (IS), Tohoku University Graduate School of Medicine, Sendai, Japan
Background
Ethanol stimulates the dopaminergic mesoaccumbal pathway, which is thought to play a role in ethanol reinforcement. Mu (μ)-opioid (MOP) receptors modulate accumbal dopamine activity, but it is not clear whether MOP receptors are involved in the mechanism of ethanol-stimulated accumbal dopamine release.
Methods
We investigated the role that MOP receptors play in ethanol (2.0 g/kg)-stimulated accumbal dopamine release by using MOP receptor knockout mice (C57BL/6J-129SvEv and congenic C57BL/6J genotypes) along with blockade of MOP receptors with a μ1 selective antagonist (naloxonazine).
Results
Both gene deletion and pharmacological antagonism of the MOP receptor decreased ethanol-stimulated accumbal dopamine release compared with controls with female mice showing a larger effect in the C57BL/6J-129SvEv genotype. However, both male and female mice showed reduced ethanol-stimulated dopamine release in the congenic MOP receptor knockout mice (C57BL/6J). No differences in the time course of dialysate ethanol concentration were found in any of the experiments.
Conclusions
The data demonstrate the existence of a novel interaction between genotype and sex in the regulation of ethanol-stimulated mesolimbic dopamine release by the MOP receptor. This implies that a more complete understanding of the epistatic influences on the MOP receptor and mesolimbic dopamine function may provide more effective pharmacotherapeutic interventions in the treatment of alcoholism.